A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2011
10/04/2011	US8030307 Bicyclic, C5-substituted proline derivatives as inhibitors of the hepatitis C virus NS3 protease
10/04/2011	US8030280 Melanoma antigens and their use in diagnostic and therapeutic methods
10/04/2011	US8030279 Tamandarin analogs and fragments thereof and methods of making and using
10/04/2011	US8030278 Methods, compositions and articles of manufacture for contributing to the treatment of cancers
10/04/2011	US8030277 Polypeptide and gene encoding the same
10/04/2011	US8030276 Treating cardiovascular disease with TRPC3 channel protein
10/04/2011	US8030275 Methods for treating obesity using fibroblast growth factor-like polypeptides
10/04/2011	US8030274 Therapeutic comprising fibroblast growth factor-2 for use in treatment and prevention of asthma and respiratory system disorders
10/04/2011	US8030273 Protracted exendin-4 compounds
10/04/2011	US8030272 Lactoferrin compositions and methods of wound treatment
10/04/2011	US8030271 Compositions and methods for buccal delivery of human growth hormone
10/04/2011	US8030270 Methods for identifying GLP-1 secretagogues
10/04/2011	US8030269 Calcitonin drug-oligomer conjugates, and uses thereof
10/04/2011	US8030074 In vivo incorporation of unnatural amino acids
10/04/2011	US8030067 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
10/04/2011	US8030046 Mutations in OAS1 genes
10/04/2011	US8030015 Tumor-inhibiting protein and the use thereof
10/04/2011	US8029830 Composition and method for promoting internal health and external appearance
10/04/2011	US8029816 Medical device coated with a coating containing elastin pentapeptide VGVPG
10/04/2011	US8029815 Methods for treating or preventing restenosis and other vascular proliferative disorders
10/04/2011	US8029809 Bacteriocins and novel bacterial strains
10/04/2011	US8029808 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
10/04/2011	US8029796 Therapeutic anti-cytomegalovirus compounds
10/04/2011	US8029793 Anticancer agents; rheumatic diseases; osteoporosis; antiinflammatory agents; cloning genes
10/04/2011	US8029791 Modified chimeric polypeptides with improved pharmacokinetic properties
10/04/2011	US8029788 Variants of humanized anti-carcinoma MAb CC49
10/04/2011	US8029786 Antibodies against a peptide epitope of apolipoprotein B
10/04/2011	US8029784 Method for the diagnosis and prognosis of malignant diseases
10/04/2011	US8029781 Methods of treating a deficiency of functional tripeptidyl peptidase I (CLN2) protein
10/04/2011	US8029780 Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same
10/04/2011	US8029778 Methods of using TICAM-1, an adapter protein that binds toll-like receptor 3
10/04/2011	US8029775 Methods of determining dose of IL-31 agonist to treat pulmonary inflammation
10/04/2011	US8029774 Wound healing polymeric networks
10/04/2011	US8029769 Protein formulation
10/04/2011	US8029768 pharmaceutical composition for pulmonary delivery comprises glycopyrrolate in a controlled release formulation, wherein, on administration, the glycopyrrolate exerts its pharmacological effect over a period greater than 12 hours.
10/04/2011	US8029755 particulate tricalcium phosphate (TCP) having an average particle size of about 5 mu m or less, an average crystal size of about 250 nm or less and a surface area of about 20 m2/g or greater;
10/04/2011	US8029609 Ejection liquid, ejection device, ejection cartridge, and method of making droplets from liquid
10/04/2011	CA2521038C Polypeptide comprising cell adhesion motif, t cell epitope and b cell epitope for inducing antibody production
10/04/2011	CA2480308C Antisense iap nucleobase oligomers and uses thereof
10/04/2011	CA2478099C Inhibitors
10/04/2011	CA2452871C Oxymorphone controlled release formulations
10/04/2011	CA2431199C Immunotherapeutic kit for the treatment of tumors
10/04/2011	CA2338886C Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response
10/04/2011	CA2285658C Direct expression of peptides into culture media
10/04/2011	CA2262819C Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein
10/04/2011	CA2245702C Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
09/2011
09/29/2011	WO2011120032A1 Methods for treating combined radiation and thermal injury
09/29/2011	WO2011120013A2 Vista regulatory t cell mediator protein, vista binding agents and use thereof
09/29/2011	WO2011119939A2 Manipulation of calcium channels to regulate after-depolarization events in cardiac myocytes
09/29/2011	WO2011119836A1 Methods and compositions for cardioprotection and cardioregeneration
09/29/2011	WO2011119833A2 Bmp-7 peptides & methods of use
09/29/2011	WO2011119829A1 Bmp-4 peptides & methods of use
09/29/2011	WO2011119759A1 Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc.
09/29/2011	WO2011119738A2 Methods of treatment using stem cell mobilizers
09/29/2011	WO2011119657A1 Novel peptides and methods for their preparation and use
09/29/2011	WO2011119628A2 Compositions and methods for self-adjuvanting vaccines against microbes and tumors
09/29/2011	WO2011119608A1 Peptides that specifically target amyloid deposits
09/29/2011	WO2011119199A1 Method of supressing cancer, increasing weight loss and/or increasing insulin sensitivity
09/29/2011	WO2011119174A1 Treating allergy with detoxified e. coli heat-labile enterotoxin
09/29/2011	WO2011119136A1 Prophylactic and therapeutic treatment of neuro-degenerative diseases and protein aggregation diseases
09/29/2011	WO2011119009A2 Peptides for promoting angiogenesis and an use thereof
09/29/2011	WO2011119008A2 Peptides for promoting angiogenesis and an use thereof
09/29/2011	WO2011118981A2 Novel use of erythroid differentiation regulator 1 as an agent for treating cancer
09/29/2011	WO2011118928A2 Pharmaceutical composition for preventing or treating heart failure and method for screening agent for preventing or treating heart failure
09/29/2011	WO2011118810A1 Nutritional composition
09/29/2011	WO2011118795A1 Composition for treatment of damaged part
09/29/2011	WO2011118779A1 Pharmaceutical composition for treatment and prevention of herpesvirus infections
09/29/2011	WO2011118481A1 Method for reducing unpleasant taste
09/29/2011	WO2011117851A1 Transdermal administration of peptides
09/29/2011	WO2011117582A1 Dendritic cell inhibitory proteins from ticks
09/29/2011	WO2011117559A1 Proangiogenic compositions, method for preparing same, and uses thereof
09/29/2011	WO2011117448A1 Compounds for use in the treatment of diseases based on the expression of toxic transcripts
09/29/2011	WO2011117417A1 Novel glucagon analogues
09/29/2011	WO2011117416A1 Novel glucagon analogues
09/29/2011	WO2011117415A1 Novel glucagon analogues
09/29/2011	WO2011117328A1 Method and compositions to induce apoptosis of tumoral cells expressing shh
09/29/2011	WO2011116655A1 Antigen for increasing cd4+cd25+foxp3+ regulatory t cells and uses thereof
09/29/2011	WO2011076095A8 Methods and compositions related to reduced met phosphorylation by leukocyte cell-derived chemotaxin 2 in tumor cells
09/29/2011	WO2011072292A3 Phase changing formulations of rna and rna derivatives
09/29/2011	WO2011072099A3 Compositions and methods comprising protease variants
09/29/2011	WO2011070214A8 Conjugates and compositions for immunotherapy and anti-tumor treatment
09/29/2011	WO2011063140A3 Implantable bone graft materials
09/29/2011	WO2011060144A3 Compositions and methods to protect cells by blocking entry of pathogen proteins
09/29/2011	WO2011056793A3 Composition, method, and kit for alpha-1 proteinase inhibitor
09/29/2011	WO2011056447A3 Methods and kits for preventing hypoglycemia
09/29/2011	WO2011053825A3 Compositions and methods for the treatment or prevention of mitochondrial diseases
09/29/2011	WO2011050379A9 Use of gstp1
09/29/2011	WO2011047135A3 Compositions and methods for treating bladder cancer
09/29/2011	WO2011047093A3 Stem cells for musculoskeletal tissue repair
09/29/2011	WO2011044452A3 Methods and compositions for amelioration of autoimmune disease using fusion proteins of anti-dendritic cell receptor antibody to peptide sequences
09/29/2011	WO2011044329A3 Devices, systems and methods for cell modification
09/29/2011	WO2011031713A3 Method for the treatment of pulmonary disease and method of producing proteins of use therein
09/29/2011	WO2011031301A3 Intrapericardial delivery of periostin
09/29/2011	WO2011022725A9 Mimotopes of hiv and uses thereof
09/29/2011	WO2010132370A3 Soluble tlt-1 for the treatment and diagnosis of sepsis
09/29/2011	WO2010103116A3 Method of treating eczema
09/29/2011	WO2007127841A3 Compositions and methods of preparation thereof
09/29/2011	US20110239318 Methods for producing fish with high lipid content
09/29/2011	US20110239317 Polynucleotides encoding promyostatin polypeptides
09/29/2011	US20110239311 Agonists of NR2F6 For Immunosupression

1 ... 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 ... 3163